Medicinal composition for treating renal carcinoma

Abstract

The invention discloses a medicinal composition for treating renal carcinoma. The medicinal composition is prepared from the following raw materials in parts by weight: 10-20 parts of desert cistanche, 10-30 parts of eucommia ulmoides, 10-20 parts of ginseng, 10-30 parts of rhizoma atractylodis macrocephalae, 10-20 parts of Chinese angelica, 10-30 parts of astragalus membranaceus, 10-30 parts of smoked plum, 10-30 parts of cynomorium songaricum, 10-20 parts of yam, 10-30 parts of pseudo-ginseng, 10-20 parts of pangolin scales, 10-30 parts of monkshood, 10-20 parts of tortoiseshell, 10-20 parts of turtle shell, 10-20 parts of dragon blood, 10-30 parts of sichuan lovage rhizome, 10-20 parts of salviae miltiorrhizae, 10-30 parts of nightshade, 10-30 parts of Indian strawberry, 10-20 parts of manyleaf paris rhizome, 10-20 parts of donkey-hide gelatin, 10-30 parts of indigo naturalis and 10-30 parts of mercurous chloride. The medicinal composition can be used for effectively treating renal carcinoma diseases and remarkably improving human disease resistance and promoting repairing of renal functions, and has the characteristics of good curative effect and little side effect.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating kidney cancer. Background technique [0002] Renal cancer is a malignant tumor originating from the urinary tubular epithelial system of the renal parenchyma. Includes various subtypes of renal cell carcinoma originating from different parts of the urinary tubule, but excludes tumors of renal interstitial origin and tumors of the renal pelvis. The etiology of renal cancer is unknown, and the most common symptoms of renal cancer are low back pain and hematuria, and a small number of patients come to the hospital for abdominal mass; 10% to 40% of patients develop paraneoplastic syndrome, manifested as hypertension, anemia, weight loss, and cachexia , fever, polycythemia, abnormal liver function, hypercalcemia, hyperglycemia, increased erythrocyte sedimentation rate, neuromuscular disease, amyloidosis, galactorrhea, abn...

AI Technical Summary

Problems solved by technology

At present, there are many traditional Chinese medicines for the treatment of kidney cancer. For example, the Chinese invention patent with the authorized announcement number CN101518607B discloses a Chinese medicine for the treatment of kidney cancer. 0.6-4 parts of head, 0.4-3 parts of frankincense, 0.4-3 parts of myrrh, 0.6-4 parts of Panax notoginseng, 0.6-4 parts of Caoheche, 1.2-7 parts of rehmannia, 1.2-7 parts of angelica, Scutellaria barbata 0.5-4 parts, 0.5-4 parts of black nightshade, 0.2-1.8 parts of bezoar, 0.1-0.6 parts of borneol, and 1.2-7 parts of wolfberry. The prevention and treatment effect of kidney function restoration and improvement of human body's disease resistance is poor